Here Are the Major Deals Facing Antitrust Reviews
Merger regulators in the US and Europe have taken more aggressive stances on deals and companies have been
1970-01-01 08:00
White House Asks Walgreens, CVS, Walmart for Help Promoting Drug-Cost Law
Biden administration officials asked executives from major drug and retail chains to counter stiff opposition from the pharmaceutical
1970-01-01 08:00
J&J Ordered to Pay $18.8 Million Over Man’s Talc-Cancer Claims
Johnson & Johnson was ordered to pay $18.8 million to a California man who blames the company’s talcum-based
1970-01-01 08:00
Eye Disease Drugmaker’s Value Halved After Severe Reactions
Apellis Pharmaceuticals Inc. shares suffered their worst two-day drop on record after confirming reports that some patients experienced
1970-01-01 08:00
Novartis Raises Outlook, Plans Buyback of Up to $15 Billion
Novartis AG raised its profit outlook and announced plans to buy back as much as $15 billion in
1970-01-01 08:00
China Foreign Minister’s Mystery Absence Fuels Black Box Concern
The mystery three-week absence of China’s Foreign Minister Qin Gang, considered a rising star of Chinese politics, is
1970-01-01 08:00
Medicare Proposes Expanding Patient Access to Alzheimer’s Scans
The US Medicare program will roll back rules that limited coverage for an expensive imaging scan for people
1970-01-01 08:00
Astra, Sanofi RSV Drug Approved in US for Use in Infants
AstraZeneca Plc and Sanofi’s drug for RSV in infants was approved in the US, the first-ever preventive intended
1970-01-01 08:00
Chinese Province Saw Cremations Surge 73% as Covid Hit: Caixin
Cremations in one of China’s most populous provinces surged by 72.7% year-on-year in the first quarter, local media
1970-01-01 08:00
Lilly Applies for Alzheimer’s Drug’s US Approval After Trial Success
Eli Lilly & Co. said it applied for full US approval of its Alzheimer’s disease drug that’s expected
1970-01-01 08:00
Pfizer’s $43 Billion Seagen Takeover Faces EU Investigation
Pfizer Inc.’s proposed $43 billion takeover of Seagen Inc. will face an investigation from the European Union’s merger
1970-01-01 08:00
Pfizer’s $43 Billion Seagen Takeover Faces FTC Scrutiny
Pfizer Inc.’s proposed $43 billion takeover of Seagen Inc. will undergo an in-depth antitrust review by the Federal
1970-01-01 08:00